Clinical Trial Update: MRI of the Liver With Eovist

View source ↗

Summary

This clinical trial update notes the termination of a study evaluating Eovist for MRI of the liver in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• EOVIST (GADOXETATE DISODIUM)

Snippet

Sponsor: University of Washington | Conditions: Hepatocellular Carcinoma | Status: TERMINATED